Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials

Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials

Abstract Background The efficacy of neoadjuvant immunotherapy in resectable non-small-cell lung cancer (NSCLC) is controversial. The aim of this study is to explore the efficacy of additional PD-1/PD-L1 inhibitors in the neoadjuvant treatment of resctable NSCLC. Methods Data sources included Cochran...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiming Zhang, Tianfu Dai, Dongying Wang, Yushu Zhu, Weicong Hua
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Cancer
Subjects:
NSCLC
Prognosis
Meta-analysis
RCT
EFS
OS
Online Access:https://doi.org/10.1186/s12885-024-13311-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items